NASDAQ: HQY · Healthcare Information Services
HealthEquity (HQY) fair value and price range
As of 14 Nov 2026, Faircurve's model values HealthEquity (HQY) at $104.84 a share. The stock last closed at $104.58, which puts the model's fair value 0.2% above the price. The model grades the evidence behind this valuation as low, so no verdict is shown. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not say how likely the fair value is to be right.
Revalued . Price is the close of 16 Nov 2026. HealthEquity, Inc.
The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 14 Nov 2026 moved the fair value from $107.21 to $104.84 (-2.2%). The model's quality adjustment to the peer multiple moved, lowering the fair value: most of the move.
What the model makes of itThe price of $104.58 is level with it. The model grades the evidence behind this valuation as low, so no verdict is shown. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not say how likely the fair value is to be right.
What's nextReports on 1 Dec 2026. Options expiring after the report price a move of about 9% either way. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give HQY?
The calibrated range for HQY over 63 trading days is $91.60 to $120.19. It sits around the last close, and its width comes from the volatility that HQY's own options imply (40% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $62.28 to $168.80. In 51% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 14 Nov 2026
HealthEquity, Inc. (HQY) is headquartered in Draper, Utah, and was established in 2002. It furnishes technology-powered service platforms to individual consumers and employers across the United States.
Faircurve's model put the fair value at $104.84 a share on 14 Nov 2026, the midpoint of 2,000 simulations. The previous run, on 7 Nov 2026, gave $107.21, so the fair value moved -2.2%. The model says its quality adjustment to the peer multiple moved, lowering the fair value: most of the move. The calibrated range over 63 trading days runs from $91.72 to $117.41, built around the price from implied volatility and calibrated weekly against 8,038 past valuations. Ranges built this way held the price 60% of the time at this horizon. The model grades the evidence as low, so no verdict is shown. The grade covers input completeness, comparable companies and range width. It does not say whether the fair value is right.
The business scores 70 out of 100 on the model's composite of six quality factors, measured against comparable companies. Capital discipline stands out at 81, with net buybacks at 4.7% of market value against a peer median of 1.0%. Profitability scores 80, with ROIC of 9.9% against a peer median of -18.3%. The model compares it with Doximity, Inc. (DOCS), Waystar Holding Corp. (WAY), Privia Health Group, Inc. (PRVA), Certara, Inc. (CERT), Omnicell, Inc. (OMCL) and HealthStream, Inc. (HSTM).
Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does HQY report earnings, and how has the stock reacted?
HealthEquity's next earnings report is scheduled for 1 Dec 2026. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 9.3% in either direction through the nearest expiry, about 31 days out, a window that includes the report. That is the size the market is pricing, not a direction. HQY's 30 day implied volatility works out to about 11.6% over one month.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across HQY's last 8 reports, ignoring direction, was 4.4%.
What the options market has priced for a month's move in HQY
How does HQY score on business quality?
HealthEquity's overall quality score is 70 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 80 | 9.9%ROIC | -18.3% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 95 | 1.99xFCF / net income | |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 50 | 9.5%Revenue growth, trailing | 28.4% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 81 | 4.7%Net buybacks / market value | 1.0% |
| Balance sheetNet debt to EBITDA and interest coverage. | 54 | 1.44xNet debt / EBITDA | |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 42 | 5.8 ptsEBITDA margin downside volatility, 5y | 6.2 pts |
How does HQY compare with similar companies?
The companies in healthcare information services closest to HealthEquity in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| DOCS Doximity, Inc. | $32.77 | $32.13 | -2.0% | Fairly valued |
| WAY Waystar Holding Corp. | $28.11 | $30.05 | +6.9% | Fairly valued |
| BTSG BrightSpring Health Services, Inc. Common Stock | $71.37 | $68.74 | -3.7% | Low evidence grade |
| PRVA Privia Health Group, Inc. | $25.26 | $21.92 | -13.2% | Overvalued |
| CERT Certara, Inc. | $11.39 | $11.49 | +0.9% | Fairly valued |
| OMCL Omnicell, Inc. | $35.44 | $37.58 | +6.0% | Fairly valued |
| HSTM HealthStream, Inc. | $27.68 | $27.45 | -0.8% | Fairly valued |
What the comparable companies' multiples alone would give for HQY, the peer-implied price, is $109.33 a share on this run. The fair value weighs that against the company's own multiple.
All healthcare information services stocks ranked by gap to fair value
HealthEquity at a glance
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States.
- Market value
- $8.6B
- Sector
- Healthcare
- Industry
- Healthcare Information Services
- Revenue expected, next twelve months
- $1.5B
- Consensus revenue growth, next fiscal year
- +7.9%
- Analysts with estimates
- 10
- Beta to the US market
- 0.48
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model prices HealthEquity on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for HQY was $107.21. As of 14 Nov 2026 it is $104.84, a change of -2.2%. The model's quality adjustment to the peer multiple moved, lowering the fair value: most of the move. The model revalues every stock it covers each week, and again after an earnings report.
Questions about HealthEquity's valuation
Is HealthEquity stock undervalued or overvalued?
Faircurve's model puts HQY's fair value at $104.84 a share against a last close of $104.58, as of 14 Nov 2026. The model grades the evidence behind this valuation as low, so no verdict is shown. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not say how likely the fair value is to be right.
What is HQY's fair value?
$104.84 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $62.28 to $168.80.
What price range does the model give HQY?
$91.60 to $120.19 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does HealthEquity report earnings next?
The next report is scheduled for 1 Dec 2026. Companies can move their dates.
How much has HQY moved on past earnings reports?
Across its last 8 reports the median two session move was 4.4%, ignoring direction. The largest was -16.3% around the report of 18 Mar 2025.
How confident is the model in this valuation?
The model's evidence grade for HQY is low. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on HQY
The model holds no idea open on HQY today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on HQY with their outcomes. A free account is enough.